GenVault
acquired by Thermo Fisher ScientificFounded 2020 · 25 employees on LinkedIn · 5 known investors
Find your way into GenVault
Sign up to see every warm intro you have to GenVault
- Paths you didn't know you had: your email and LinkedIn already hold routes to the GenVault team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
GenVault operates a GxP-compliant biorepository providing secure, temperature-controlled storage, sample management, and lab relocation services for biological, clinical, and biopharmaceutical materials. It serves pharma, biotech, academia, CROs, CDMOs, and government clients, offering ambient/CRT, cold room, freezer/ULT, and cryogenic storage backed by ISO, CAP, and FDA certifications.
Investors · 5
How we know: Cross Creek Advisors's portfolio page · Not right? Tell us
How we know: QuestMark Partners's portfolio page · biospace.com · Not right? Tell us
How we know: funding news · biospace.com · Not right? Tell us
In the news
Frequently asked questions
- What does GenVault do?
- GenVault operates a GxP-compliant biorepository providing secure, temperature-controlled storage, sample management, and lab relocation services for biological, clinical, and biopharmaceutical materials. It serves pharma, biotech, academia, CROs, CDMOs, and government clients, offering ambient/CRT, cold room, freezer/ULT, and cryogenic storage backed by ISO, CAP, and FDA certifications.
- Who are GenVault's investors?
- GenVault's investors include Cross Creek Advisors, QuestMark Partners, Domain Associates, Greenspring Associates, In-Q-Tel.
- Who acquired GenVault?
- GenVault was acquired by Thermo Fisher Scientific.


